Marie A. Bogoyevitch

Marie A. Bogoyevitch

Auto-generated profile, based on publicly available information

Marie A. Bogoyevitch

Department of Biochemistry and Molecular Biology, University of Melbourne

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2006 in Microbiology and Molecular Biology Reviews
Verified
Journal Article
Closed access
MBMarie A. Bogoyevitch
Marie A. Bogoyevitch
BKBostjan Kobe
Bostjan Kobe
SUMMARY: The c-Jun N-terminal kinases (JNKs) are members of a larger group of serine/threonine (Ser/Thr) protein kinases from the mitogen-activated protein kinase family. JNKs were originally identified as stress-activated protein kinases in the livers of cycloheximide-challenged rats. Their subsequent purification, cloning, and naming as JNKs have emphasized their ability to phosphorylate and activate the transcription factor c-Jun. Studies of c-Jun and related transcription factor substrates have provided clues about both the preferred substrate phosphorylation sequences and additional docking domains recognized by JNK. There are now more than 50 proteins shown to be substrates for JNK. These include a range of nuclear substrates, including transcription factors and nuclear hormone receptors, heterogeneous nuclear ribonucleoprotein K, and the Pol I-specific transcription factor TIF-IA, which regulates ribosome synthesis. Many nonnuclear substrates have also been characterized, and these are involved in protein degradation (e.g., the E3 ligase Itch), signal transduction (e.g., adaptor and scaffold proteins and protein kinases), apoptotic cell death (e.g., mitochondrial Bcl2 family members), and cell movement (e.g., paxillin, DCX, microtubule-associated proteins, the stathmin family member SCG10, and the intermediate filament protein keratin 8). The range of JNK actions in the cell is therefore likely to be complex. Further characterization of the substrates of JNK should provide clearer explanations of the intracellular actions of the JNKs and may allow new avenues for targeting the JNK pathways with therapeutic agents downstream of JNK itself.

1 September 2016 in Microbiology and Molecular Biology Reviews
Verified
Journal Article
Open access
PDF file
AZAndrás Zeke
András Zeke
MMMariya Misheva
Mariya Misheva
ARAttila Reményi
Attila Reményi
MBMarie A. Bogoyevitch
Marie A. Bogoyevitch
SUMMARY The c-Jun N-terminal kinases (JNKs), as members of the mitogen-activated protein kinase (MAPK) family, mediate eukaryotic cell responses to a wide range of abiotic and biotic stress insults. JNKs also regulate important physiological processes, including neuronal functions, immunological actions, and embryonic development, via their impact on gene expression, cytoskeletal protein dynamics, and cell death/survival pathways. Although the JNK pathway has been under study for >20 years, its complexity is still perplexing, with multiple protein partners of JNKs underlying the diversity of actions. Here we review the current knowledge of JNK structure and isoforms as well as the partnerships of JNKs with a range of intracellular proteins. Many of these proteins are direct substrates of the JNKs. We analyzed almost 100 of these target proteins in detail within a framework of their classification based on their regulation by JNKs. Examples of these JNK substrates include a diverse assortment of nuclear transcription factors (Jun, ATF2, Myc, Elk1), cytoplasmic proteins involved in cytoskeleton regulation (DCX, Tau, WDR62) or vesicular transport (JIP1, JIP3), cell membrane receptors (BMPR2), and mitochondrial proteins (Mcl1, Bim). In addition, because upstream signaling components impact JNK activity, we critically assessed the involvement of signaling scaffolds and the roles of feedback mechanisms in the JNK pathway. Despite a clarification of many regulatory events in JNK-dependent signaling during the past decade, many other structural and mechanistic insights are just beginning to be revealed. These advances open new opportunities to understand the role of JNK signaling in diverse physiological and pathophysiological states.

1 August 1996 in Circulation Research
Verified
Journal Article
Closed access
MBMarie A. Bogoyevitch
Marie A. Bogoyevitch
JGJudith Gillespie-Brown
Judith Gillespie-Brown
AKAlbert J. Ketterman
Albert J. Ketterman
SFStephen J. Fuller
Stephen J. Fuller
RBRachel Ben-Levy
Rachel Ben-Levy
PSPeter H. Sugden
Peter H. Sugden
It has recently been recognized that cellular stresses activate certain members of the mitogen-activated protein kinase (MAPK) superfamily. One role of these “stress-activated” MAPKs is to increase the transactivating activity of the transcription factors c-Jun, Elk1, and ATF2. These findings may be particularly relevant to hearts that have been exposed to pathological stresses. Using the isolated perfused rat heart, we show that global ischemia does not activate the 42- and 44-kD extracellular signal–regulated (protein) kinase (ERK) subfamily of MAPKs but rather stimulates a 38-kD activator of MAPK-activated protein kinase-2 (MAPKAPK2). This activation is maintained during reperfusion. The molecular characteristics of this protein kinase suggest that it is a member of the p38/reactivating kinase (RK) group of stress-activated MAPKs. In contrast, stress-activated MAPKs of the c-Jun N-terminal kinase (JNK/SAPKs) subfamily are not activated by ischemia alone but are activated by reperfusion following ischemia. Furthermore, transfection of ventricular myocytes with activated protein kinases (MEKK1 and SEK1) that may be involved in the upstream activation of JNK/SAPKs induces increases in myocyte size and transcriptional changes typical of the hypertrophic response. We speculate that activation of multiple parallel MAPK pathways may be important in the responses of hearts to cellular stresses.

1 March 2010 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
MBMarie A. Bogoyevitch
Marie A. Bogoyevitch
KNKevin R.W. Ngoei
Kevin R.W. Ngoei
TZTeresa T. Zhao
Teresa T. Zhao
YYYvonne Y.C. Yeap
Yvonne Y.C. Yeap
DNDominic Ng
Dominic Ng

1 November 2001 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
RBRenae K. Barr
Renae K. Barr
MBMarie A. Bogoyevitch
Marie A. Bogoyevitch

1 March 2004 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
MBMarie A. Bogoyevitch
Marie A. Bogoyevitch
IBIngrid Boehm
Ingrid Boehm
Aaron OakleyAaron Oakley
Aaron Oakley
AKAlbert J. Ketterman
Albert J. Ketterman
RBRenae K. Barr
Renae K. Barr